Table 1.
Characteristic | Results |
---|---|
Number of patients | 24 |
Age | 62 ± 10.3 (43–90) |
Gender | |
Male | 20 (83.3%) |
Female | 4 (16.7%) |
Lesion location | 30 |
ICA | 6 (20%) |
MCA | 14 (46.6%) |
BA | 3 (10%) |
VA | 7 (23.3%) |
Enterprise stent size | |
Diameter (mm) | 4.5 |
Length (mm) | 23.5 ± 4.4 (22–37) |
Lesion characteristics | |
Mean pre-treated stenosis degree | 81 ± 11.3% |
Mean post-treated stenosis degree | 18 ± 6.8% |
Clinical outcome (mean follow-up of 15.8 months) | |
Morbidity (per lesion) | |
Post-procedural complication within 30 days (Early) | 3 (10%) |
Post-procedural complication 30 days later (Late) | 0 (0%) |
Modified Rankin Score (At presentation / at follow-up of at least 6 months) | |
Good (0–2) | 16 (66%)/20 (83%) |
Moderate to poor (3–6) | 8 (34%)/4 (17 %) |
Angiographic outcome (mean follow-up of 15.4 months) | |
Follow-up patients | 17 |
Available follow-up lesions | 20 |
In-stent restenosis | 1/20 (5.0%) |